Status:
RECRUITING
Penn Medicine Healthy Heart
Lead Sponsor:
University of Pennsylvania
Conditions:
Hypertension
Hyperlipidemias
Eligibility:
All Genders
35-80 years
Phase:
NA
Brief Summary
To leverage access to patients across the primary care network, EPIC tools for identifying eligible patients, and the Way to Health platform to launch and enroll a program that will be evaluated in a ...
Detailed Description
To leverage access to patients across the primary care network, EPIC tools for identifying eligible patients, and the Way to Health platform to launch and enroll Penn Medicine primary care patients in...
Eligibility Criteria
Inclusion
- On the Penn Medicine Primary Care Service Line registry
- Last 2 Blood Pressure readings with Systolic Blood Pressure \>=140 from any outpatient encounter in the last 12 months AND
- ASCVD dx OR ASCVD risk score ≥10% OR Diabetes dx OR A1c ≥6.5 in last year OR Diabetes registry OR Last LDL ≥190 in past five years AND
- Not on a statinor PCSK9, Inclisiran OR on a Low-intensity/moderate-intensity statin) with LDL \>100
Exclusion
- Patients on PCSK9 inhibitors
- Documented statin allergy/ or intolerance in the EMR
- Pregnancy
- Breast feeding
- Markedly shortened life expectancy including:
- metastatic cancer
- hospice
- End Stage Renal Disease
- Congestive Heart Failure
- Dementia
- Is a non-English speaker requiring a translator
- Patients who do not have a cell phone
Key Trial Info
Start Date :
March 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
1980 Patients enrolled
Trial Details
Trial ID
NCT06062394
Start Date
March 11 2024
End Date
April 1 2026
Last Update
April 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn Medicine
Philadelphia, Pennsylvania, United States, 19104